Biotechnology research and development laboratories or services in the medical sciences · Massachusetts
Syros Pharmaceuticals, Inc.
Cambridge, MA · ~106 workers · 3 years of OSHA Injury Tracking Application data.
- D
- Poor Safety Record
- 0.6
- Avg TCR
- 0.5
- Industry avg
- 0
- Fatalities
The verdict
Syros Pharmaceuticals, Inc. runs at 124% of its industry's injury rate - more dangerous than the typical Biotechnology research and development laboratories or services in the medical sciences workplace, earning a grade D.
Syros Pharmaceuticals, Inc.: 0.6 TCR = 124% of Biotechnology research and development laboratories or services in the medical sciences BLS 0.5 · 3y Form 300A (see methodology below)
Syros Pharmaceuticals, Inc. safety composite
Syros Pharmaceuticals, Inc. scores strongest on dart rate (safer than 76% of same-industry peers) and weakest on fatalities (safer than 50%), blended into one 0-100 breakdown against same-industry peers. A missing measure drops out and redistributes its weight rather than deflating the score. This is a per-dimension breakdown, distinct from the single letter grade above it (which weights TCR alone against the BLS industry benchmark).
62/100
Percentile-weighted across 3 of 3 measures
- Total Case Rate (TCR)
- C 0.62 per 100 workers
Safer than 58% of industry peers
- DART rate
- B 0 per 100 workers
Safer than 76% of industry peers
- Fatalities
- D 0
Safer than 50% of industry peers
Benchmarked live against every credibly-rated employer in the same NAICS industry code in the current OSHA extract (a segment must have at least 8 rated peers to benchmark). Not a legal or compliance determination; PlainSafetyScore's own weighting (TCR 40%, DART 35%, fatalities 25%).
TCR Δ
−1.1
2020→2023
Syros Pharmaceuticals, Inc. injury rate improved
Syros Pharmaceuticals, Inc.'s TCR fell 1.1 from 1.1 in 2020 to 0.0 in 2023. Peak filing year was 2020 at 1.1 TCR. In 2023, DART was 0× this establishment's average TCR (severity share of cases).
2020=1.1 · 2021=0.8 · 2023=0.0
OSHA ITA Form 300A scorecard
Establishment book 541711 · Cambridge, MA ABOVE-IND · MID
Grade D · TCR 0.6 · 124% of ind
- DART 0.0 DART
- RANK #17/23
- PHOTO Novartis Institutes …
- BOOK 3y book
- INJ 1 inj
- SIZE ~106 FTE
Nearest TCR peer: Novartis Institutes for Biomedical Research, Inc (0.0 TCR gap)
Read with this employer → · Industry book → · Massachusetts employers → · Look up another →
Syros Pharmaceuticals, Inc. in the TCR neighbourhood
Average Total Case Rate among this establishment and nearest same-industry peers
- This site
Syros Pharmaceuticals, Inc.
0.6 TCR
- Novartis Insti
Novartis Institutes for Biomedical Research, Inc
0.6 TCR
- Vyriad
Vyriad
0.6 TCR
- Battelle Colum
Battelle Columbus Operations
0.6 TCR
- Hopewell
Hopewell
0.6 TCR
What this shows Syros Pharmaceuticals, Inc. averages 0.6 TCR (124% of the Biotechnology research and development laboratories or services in the medical sciences BLS benchmark).
Syros Pharmaceuticals, Inc. TCR series: 2020=1.1 · 2021=0.8 · 2023=0 · BLS 0.5
Where Syros Pharmaceuticals, Inc. falls in its industry
189 Biotechnology research and dev establishmentsSafer than 58% of graded establishments in this industry, whose median TCR is 0.8.
Narrower to Massachusetts alone (the establishments it most directly competes with for workers and contracts): ranked #17 safest of 23 Biotechnology research and dev employers in Massachusetts.
Syros Pharmaceuticals, Inc. has fewer employees than the Biotechnology research and development l median and a lower injury rate than the industry's median TCR of 0.8. Workforce size and injury rate do not always move together within the same industry -- some of its smaller peers run higher rates than its larger ones, and vice versa.
Year-by-Year Safety Data
| Year | TCR | DART | Injuries | Illnesses | Fatalities |
|---|---|---|---|---|---|
| 2023 | 0.0 | 0.0 | 0 | 0 | 0 |
| 2021 | 0.8 | 0.8 | 0 | 1 | 0 |
| 2020 | 1.1 | 1.1 | 1 | 0 | 0 |
OSHA ITA peer cross-reference
Establishment peer ledger
541711 · MA · Cambridge
189 Biotechnology research and development laboratories or services in the medical sciences employers nationwide with a credible TCR · 10,108 rated employers in Massachusetts with headcount on file · 149 employers in Cambridge, MA · 4 cross-state NAT-TCR peers · 4 cross-state NAT-SIZE peers. Closest matches by relationship code are listed below.
| Rel | Establishment | Metric |
|---|---|---|
| NAICS-TCR | Novartis Institutes for Biomedical Research, Inc | 0.6 TCR |
| NAICS-TCR | Vyriad | 0.6 TCR |
| NAICS-TCR | Battelle Columbus Operations | 0.6 TCR |
| NAICS-TCR | Hopewell | 0.6 TCR |
| STATE-SIZE | Eversource - Lawrence | 106 FTE |
| STATE-SIZE | E.T.& L. Corp. | 106 FTE |
| STATE-SIZE | MAS Building & Bridge, Inc. | 106 FTE |
| STATE-SIZE | Methuen | 106 FTE |
| CITY-NEAR | Philips NAM Field Sales & Service | 5,136 FTE |
| CITY-NEAR | Vinfen Corporation | 2,662 FTE |
| CITY-NEAR | Biogen - Cambridge | 2,478 FTE |
| CITY-NEAR | Cambridge Campus | 2,473 FTE |
| NAT-TCR | People Haulers, Inc. | 0.6 TCR |
| NAT-TCR | Cheyenne - Cleveland | 0.6 TCR |
| NAT-TCR | Mid-Atlantic Division Master Log | 0.6 TCR |
| NAT-TCR | Sodexo at Doane College | 0.6 TCR |
| NAT-SIZE | Warehouse #2 | 106 FTE |
| NAT-SIZE | Wayne County Eggs LLC | 106 FTE |
| NAT-SIZE | Hebeler LLC. | 106 FTE |
| NAT-SIZE | Bel Air Continuing Care Center Ltd. Co. d/b/a Bel Air at Teravista | 106 FTE |
Rel codes: NAICS-TCR · STATE-SIZE · CITY-NEAR · NAT-TCR/NAT-SIZE cross-state. Read with this employer →
Read our methodology - how this data is sourced, computed, and verified.